Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model. [electronic resource]
Producer: 20181211Description: 1734 p. digitalISSN:- 2045-2322
- Animals
- Benzamides -- pharmacology
- Bridged Bicyclo Compounds -- pharmacology
- Cell Survival -- drug effects
- Chronic Disease
- Color Vision -- drug effects
- Disease Models, Animal
- Down-Regulation -- drug effects
- GABA Antagonists -- pharmacology
- GABAergic Neurons -- metabolism
- Glaucoma -- metabolism
- Glutamate Decarboxylase -- metabolism
- Inhibitory Postsynaptic Potentials -- drug effects
- Kinetics
- Male
- Models, Biological
- Neuroprotective Agents -- pharmacology
- Ocular Hypertension -- metabolism
- Presynaptic Terminals -- metabolism
- Pyridazines -- pharmacology
- Rats, Wistar
- Retinal Ganglion Cells -- metabolism
- alpha7 Nicotinic Acetylcholine Receptor -- agonists
- gamma-Aminobutyric Acid -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.